Use of granulocyte colony-stimulating factor in patients with chemotherapy-induced neutropaenia
Background: Febrile neutropaenia (FN) and resultant infections are the major cause of treatment-related morbidity and mortality in patients receiving chemotherapy. Clinical practice guidelines recommend the use of granulocyte colony-stimulating factors (G-CSF) to reduce the risk of FN and ensuing co...
Saved in:
Main Authors: | Lucky L. Shokane (Author), Selente Bezuidenhout (Author), Maryke Lundie (Author) |
---|---|
Format: | Book |
Published: |
AOSIS,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Granulocyte colony-stimulating factor and leukemogenesis
by: Lorena Lobo de Figueiredo, et al.
Published: (2004) -
Evaluating the Prognostic Role of Monocytopenia in Chemotherapy-Induced Febrile Neutropenia Patients Treated with Granulocyte Colony-Stimulating Factor
by: Alshari O, et al.
Published: (2021) -
Granulocyte Colony-Stimulating Factor in Amniotic Fluid
by: B. Denise Raynor, et al.
Published: (1995) -
Granulocyte colony-stimulating factor and reproductive medicine: A review
by: Marcelo Borges Cavalcante, et al.
Published: (2015) -
Contrasting Immunopathogenic and Therapeutic Roles of Granulocyte Colony-Stimulating Factor in Cancer
by: Annette J. Theron, et al.
Published: (2020)